Demina Anastasia, Soudry-Faure Agnès, Petit Benjamin, Meunier-Beillard Nicolas, Trojak Benoit
Addiction Medicine Department, Dijon Bourgogne University Hospital, Dijon, France.
INSERM U1093, CAPS, Université de Bourgogne, UFR STAPS, Dijon, France.
PLoS One. 2025 Feb 20;20(2):e0318686. doi: 10.1371/journal.pone.0318686. eCollection 2025.
Tobacco use is one of the leading causes of preventable disease and death worldwide. Despite the availability of evidence-based pharmacological treatments, only a small number of individuals with tobacco use disorder achieve long-term abstinence after smoking cessation. This highlights the need to enhance existing interventions. In this protocol, we describe our single-center mixed-method trial, HowToMind, conducted in Dijon, France. This trial aims to investigate the usability and acceptability of a digital mindfulness-based intervention designed to complement standard smoking cessation treatment to potentiate its effects.
We will include 60 adults seeking treatment for tobacco use disorder, as defined by DSM-5 criteria, who wish to quit smoking and own a smartphone. All participants will receive a combination of transdermal and oral nicotine replacement therapy and will be introduced to an eHealth app that provides a digital equivalent of an 8-week mindfulness training program. The acceptability of the initial version of our app will be assessed based on usage frequency, and usability will be evaluated using the Mobile App Rating Scale (French version). A participatory approach will be employed through focus groups conducted at the end of the 8 weeks of app use, aimed at co-constructing the final version of the app based on participant feedback.
Our pilot mixed-method trial seeks to explore the usability and acceptability of our app, making necessary adjustments to its content and functionality based on participant feedback before its implementation in a large randomized controlled trial assessing the app's potential to enhance the effects of standard treatment.
ClinicalTrials.gov, NCT06500117.
烟草使用是全球可预防疾病和死亡的主要原因之一。尽管有循证药理学治疗方法,但只有少数烟草使用障碍患者在戒烟后能实现长期戒烟。这凸显了加强现有干预措施的必要性。在本方案中,我们描述了在法国第戎进行的单中心混合方法试验“HowToMind”。该试验旨在调查一种基于数字正念的干预措施的可用性和可接受性,该干预措施旨在补充标准戒烟治疗以增强其效果。
我们将纳入60名符合《精神疾病诊断与统计手册》第5版标准、寻求治疗烟草使用障碍、希望戒烟且拥有智能手机的成年人。所有参与者将接受经皮和口服尼古丁替代疗法,并将被引入一款电子健康应用程序,该程序提供相当于为期8周的正念训练计划的数字版本。我们应用程序初始版本的可接受性将根据使用频率进行评估,可用性将使用移动应用程序评分量表(法语版)进行评估。将在应用程序使用8周结束时通过焦点小组采用参与式方法,旨在根据参与者的反馈共同构建应用程序的最终版本。
我们的试点混合方法试验旨在探索我们应用程序的可用性和可接受性,在将其应用于评估该应用程序增强标准治疗效果潜力的大型随机对照试验之前,根据参与者的反馈对其内容和功能进行必要调整。
ClinicalTrials.gov,NCT06500117。